The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts

The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts

Bibliographic Details
Main Authors:	Prottengeier, Johannes, Koutsilieri, Eleni, Scheller, Carsten
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091651/

Similar Items

Euphorbia Kansui Reactivates Latent HIV
by: Cary, Daniele C., et al.
Published: (2016)

HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients
by: Kasang, Christa, et al.
Published: (2012)

Immunosuppression Facilitates the Reactivation of Latent Papillomavirus Infections
by: Maglennon, G. A., et al.
Published: (2014)

Approaches to eradication of latent HIV infection
by: Margolis, David
Published: (2013)

Attacking latent HIV: towards eradication of HIV infection
by: Margolis, DM
Published: (2006)

Autoimmunity, dendritic cells and relevance for Parkinson’s disease
by: Koutsilieri, E., et al.
Published: (2012)

Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals
by: Horn, Anne, et al.
Published: (2013)

Immunological and pharmacological strategies to reactivate HIV-1 from latently infected cells: a possibility for HIV-1 paediatric patients?
by: Martínez-Bonet, M, et al.
Published: (2015)

Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
by: Rasmussen, Thomas A., et al.
Published: (2013)

Reactivation of Latent HIV-1 Expression by Engineered TALE Transcription Factors
by: Perdigão, Pedro, et al.
Published: (2016)

Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1
by: Tyagi, Mudit, et al.
Published: (2015)

Heat Shock Factor 1 Mediates Latent HIV Reactivation
by: Pan, Xiao-Yan, et al.
Published: (2016)

The Effect of Latent Toxoplasma gondii Infection on the Immune Response in HIV-Infected Patients
by: Beran, Ondrej, et al.
Published: (2015)

Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic Pain
by: Liu, Bolong, et al.
Published: (2016)

The host cell side of latent HIV-1 infection
by: Seu, Lillian, et al.
Published: (2015)

Analysis of the Mechanism of Reactivation of Latently Infecting Pseudorabies Virus by Acetylcholine
by: TANAKA, Seiichi, et al.
Published: (2014)

Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis
by: Pérez-Lago, Laura, et al.
Published: (2015)

5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals
by: Ishida, Takaomi, et al.
Published: (2006)

A Stochastic Model of Latently Infected Cell Reactivation and Viral Blip Generation in Treated HIV Patients
by: Conway, Jessica M., et al.
Published: (2011)

Homeostatic Proliferation Fails to Efficiently Reactivate HIV-1 Latently Infected Central Memory CD4+ T Cells
by: Bosque, Alberto, et al.
Published: (2011)

Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
by: Lee, Wen Shi, et al.
Published: (2015)

Endogenous Opioid-Masked Latent Pain Sensitization: Studies from Mouse to Human
by: Pereira, Manuel P., et al.
Published: (2015)

Dissecting HIV's Latent Menace
by: Sedwick, Caitlin
Published: (2011)

Reactivation of latent melioidosis presenting with acute pyelonephritis and bacteremia
by: Shaaban, Hamid, et al.
Published: (2014)

Updates on the risk factors for latent tuberculosis reactivation and their managements
by: Ai, Jing-Wen, et al.
Published: (2016)

HIV-1 Vpr reactivates latent HIV-1 provirus by inducing depletion of class I HDACs on chromatin
by: Romani, Bizhan, et al.
Published: (2016)

Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach
by: Roux, Perrine, et al.
Published: (2011)

Genome-wide analysis of histone modifications in latently HIV-1 infected T cells
by: Park, Jihwan, et al.
Published: (2014)

Selective HDAC Inhibition for the Disruption of Latent HIV-1 Infection
by: Barton, Kirston M., et al.
Published: (2014)

Viral and Latent Reservoir Persistence in HIV-1–Infected Patients on Therapy
by: Kim, Hwijin, et al.
Published: (2006)

Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study
by: Kall, Meaghan M, et al.
Published: (2012)

Apoptosis-induced activation of HIV-1 in latently infected cell lines
by: Khan, Sohrab Z., et al.
Published: (2015)

Type I interferon responses are impaired in latently HIV infected cells
by: Ranganath, Nischal, et al.
Published: (2016)

Activation and lysis of human CD4 cells latently infected with HIV-1
by: Pegu, Amarendra, et al.
Published: (2015)

Tuberculosis Infection and Latent Tuberculosis
by: Lee, Seung Heon
Published: (2016)

Latent Malaria Infection in Monkeys
by: Knowles, R., et al.
Published: (1934)

The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons
by: Nicoll, Michael P., et al.
Published: (2016)

In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection
by: Tsai, Perry, et al.
Published: (2016)

Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial
by: Kasang, Christa, et al.
Published: (2016)

Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected
by: Gutiérrez, Carolina, et al.
Published: (2011)